DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

Gilead Sciences (NASDAQ: GILD)

110.71 3.53 (3.29%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $110.71 3.29%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.53
Previous Close $107.18
Daily Range $106.60 - $111.47
52-Week Range $63.50 - $111.47
Market Cap $167.4B
P/E Ratio 24.14
Dividend (Yield) $0.00 (0.0%)
Volume 15,105,076
Average Daily Volume 14,953,482
Current FY EPS $7.26





Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

5 Things Johnson & Johnson's Management Wants You to Know

Johnson & Johnson reported another decent quarter last week, but it only tells part of the tale of where this company is headed next. In order to get the full story we instead turn to J&J's conference call for deeper insights into the company.

Will Gilead (GILD) Miss Earnings on High Operating Costs? - Analyst Blog

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Stocks Trade Higher Ahead of News-Heavy Weekend

Today's financial recap and tomorrow's financial outlook.

Stocks Trade Higher Ahead of News-Heavy Weekend

Friday's ETF with Unusual Volume: BBH

3 Stocks Reiterated As A Buy: EBAY, DD, GILD

Fab Four - Got To Get You Into My Life

Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street

Bristol-Myers Squibb reported third-quarter earnings this morning. Here's what you need to know.

Biotech Breakout: Technical Analysis And Major News

See More GILD News...

GILD's Top Competitors

GILD $110.71 (3.29%)
Current stock: GILD
AMGN $147.26 (0.01%)
Current stock: AMGN
CELG $103.24 (2.83%)
Current stock: CELG
$0.00 (0.00%)
Current stock: